At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CURE Direxion Daily Healthcare Bull 3X ETF
Not Yet Opened 10-13 16:00:00 EDT
131.19
-5.59
-4.09%
盘后131.19
+0.000.00%
19:57 EDT
High138.30Low130.73Vol63.38K
Open138.30D1 Closing136.78Amplitude5.53%
Mkt Cap163.99MTradable Cap163.99MTotal Shares1.25M
T/O8.55MT/O Rate5.07%Tradable Shares1.25M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Eli Lilly & Co. Stock Outperforms Competitors Despite Losses on the Day
Dow Jones  ·  04:32
Eli Lilly & Co. Stock Outperforms Competitors Despite Losses on the Day
Eli Lilly's Onswik Insulin Injection Wins UK Authorization for Type 2 Diabetes
MT Newswires Live  ·  10-13 21:58
Eli Lilly's Onswik Insulin Injection Wins UK Authorization for Type 2 Diabetes
Walmart's List of Covered Medications Include Glp1s Like Novo's Ozempic and Lilly's Mounjaro, Alongside Some Insulin and Inhalers- Bloomberg News
THOMSON REUTERS  ·  10-13 21:39
Walmart's List of Covered Medications Include Glp1s Like Novo's Ozempic and Lilly's Mounjaro, Alongside Some Insulin and Inhalers- Bloomberg News
Missed Eli Lilly's Rally? Here Is What Holders Saw
Simply Wall St.  ·  10-13 11:33
Missed Eli Lilly's Rally? Here Is What Holders Saw
Sector Update: Healthcare Stocks Rise Late Afternoon
MT Newswires Live  ·  10-13 03:51
Sector Update: Healthcare Stocks Rise Late Afternoon
Eli Lilly Likely to Post Strong Volume Growth in Q3, RBC Says
MT Newswires Live  ·  10-12 23:32
Eli Lilly Likely to Post Strong Volume Growth in Q3, RBC Says
Eli Lilly Price Target Maintained with a $1500.00/Share by RBC Capital
Dow Jones  ·  10-12 22:39
Eli Lilly Price Target Maintained with a $1500.00/Share by RBC Capital
Eli Lilly & Co (LLY) Receives a Buy from Barclays
TIPRANKS  ·  10-12 17:17
Eli Lilly & Co (LLY) Receives a Buy from Barclays
Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial
Simply Wall St.  ·  10-11 15:26
Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial
1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults
Dow Jones  ·  10-09
1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults
BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating
MT Newswires Live  ·  10-09
BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)
TIPRANKS  ·  10-09
Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)
Eli Lilly announces new TOGETHER-PsO trial data
TIPRANKS  ·  10-09
Eli Lilly announces new TOGETHER-PsO trial data
Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone
Reuters  ·  10-09
Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone
Eli Lilly price target lowered to $1,341 from $1,344 at BofA
TIPRANKS  ·  10-09
Eli Lilly price target lowered to $1,341 from $1,344 at BofA
Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity
THOMSON REUTERS  ·  10-09
Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity
Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine
THOMSON REUTERS  ·  10-09
Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine
New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity
THOMSON REUTERS  ·  10-09
New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity
Top 3 Biotech Stocks To Watch In October 2026
Simply Wall St.  ·  10-09
Top 3 Biotech Stocks To Watch In October 2026
Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak
Deep News  ·  10-09
Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Introduction

Company Name.
Direxion Daily Healthcare Bull 3X ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Issue price:
--